(NASDAQ: MDLN) Medline's forecast annual revenue growth rate of 7.28% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.58%.
Medline's revenue in 2026 is $29,939,000,000.On average, 29 Wall Street analysts forecast MDLN's revenue for 2026 to be $41,881,321,865,152, with the lowest MDLN revenue forecast at $40,072,284,356,160, and the highest MDLN revenue forecast at $43,458,970,855,552. On average, 29 Wall Street analysts forecast MDLN's revenue for 2027 to be $45,153,628,812,740, with the lowest MDLN revenue forecast at $43,006,711,478,304, and the highest MDLN revenue forecast at $47,095,451,778,424.
In 2028, MDLN is forecast to generate $48,645,491,911,492 in revenue, with the lowest revenue forecast at $46,125,197,649,328 and the highest revenue forecast at $51,344,586,392,568.